Emil Wolsk1, David Kaye2, Barry A Borlaug3, Daniel Burkhoff4, Dalane W Kitzman5, Jan Komtebedde6, Carolyn S P Lam7, Piotr Ponikowski8, Sanjiv J Shah9, Finn Gustafsson1. 1. Department of Cardiology, Rigshospitalet, Copenhagen, Denmark. 2. Baker IDI Heart and Diabetes Research Institute, Melbourne, Australia. 3. Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA. 4. Cardiovascular Research Foundation, Orangeburg, NY, USA. 5. Department of Internal Medicine, School of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. 6. DC Devices, Boston, MA, USA. 7. National Heart Centre Singapore, Singapore and Duke-National University of Singapore, Singapore. 8. Department of Heart Diseases, Medical University and Centre for Heart Diseases, Military Hospital, Wrocław, Poland. 9. Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract
AIMS: Patients with heart failure and preserved ejection fraction (HFpEF) are characterized by functional impairment and an abnormal haemodynamic response to exercise. The six-minute walk test (6MWT) serves as a standardized test for functional capacity quantification in heart failure patients, and is associated with cardiovascular outcomes. However, as the association between 6MWT and haemodynamic parameters during rest and exercise in HFpEF patients is unknown, we sought to elucidate this relationship. METHODS AND RESULTS: Overall, 64 patients enrolled in the REDUCE LAP-HF trial completed a 6MWT at baseline. Univariate and multivariable linear regression models were used to assess the associations between 6MWT and measured or derived haemodynamic variables at baseline, during light/moderate exercise (20 W), and at peak supine exercise. The average 6MWT distance was 318 ± 106 m. At rest, in a multivariable model, only pulmonary capillary wedge pressure (PCWP) was significantly associated with 6MWT [coefficient: -5.4, 95% confidence interval (CI) -10.4, -0.5, P = 0.033]. During light/moderate exercise, mean pulmonary artery pressure was associated with 6MWT in a multivariable model (coefficient: -3.5, 95% CI -6.8, -0.3, P = 0.033). During peak exercise, central venous pressure, cardiac index (CI), and PCWP/CI correlated with 6MWT; however, workload corrected PCWP was the only variable independently associated with 6MWT (coefficient: -0.8, 95% CI -1.3, -0.4, P < 0.001). The variance in 6MWT was modestly explained by measured or derived haemodynamic variables at rest or at any stage of exercise (r2 = 7-17%). CONCLUSION: Workload corrected PCWP correlated best with 6MWT performance in HFpEF patients. Baseline haemodynamic variables were modestly correlated with 6MWT, suggesting that 6MWT performance in HFpEF patients may be significantly influenced by extra-cardiac factors.
AIMS: Patients with heart failure and preserved ejection fraction (HFpEF) are characterized by functional impairment and an abnormal haemodynamic response to exercise. The six-minute walk test (6MWT) serves as a standardized test for functional capacity quantification in heart failurepatients, and is associated with cardiovascular outcomes. However, as the association between 6MWT and haemodynamic parameters during rest and exercise in HFpEF patients is unknown, we sought to elucidate this relationship. METHODS AND RESULTS: Overall, 64 patients enrolled in the REDUCE LAP-HF trial completed a 6MWT at baseline. Univariate and multivariable linear regression models were used to assess the associations between 6MWT and measured or derived haemodynamic variables at baseline, during light/moderate exercise (20 W), and at peak supine exercise. The average 6MWT distance was 318 ± 106 m. At rest, in a multivariable model, only pulmonary capillary wedge pressure (PCWP) was significantly associated with 6MWT [coefficient: -5.4, 95% confidence interval (CI) -10.4, -0.5, P = 0.033]. During light/moderate exercise, mean pulmonary artery pressure was associated with 6MWT in a multivariable model (coefficient: -3.5, 95% CI -6.8, -0.3, P = 0.033). During peak exercise, central venous pressure, cardiac index (CI), and PCWP/CI correlated with 6MWT; however, workload corrected PCWP was the only variable independently associated with 6MWT (coefficient: -0.8, 95% CI -1.3, -0.4, P < 0.001). The variance in 6MWT was modestly explained by measured or derived haemodynamic variables at rest or at any stage of exercise (r2 = 7-17%). CONCLUSION: Workload corrected PCWP correlated best with 6MWT performance in HFpEF patients. Baseline haemodynamic variables were modestly correlated with 6MWT, suggesting that 6MWT performance in HFpEF patients may be significantly influenced by extra-cardiac factors.
Authors: Janet D Pierce; Qiuhua Shen; Diane E Mahoney; Faith Rahman; Kathryn J Krueger; Francisco J Diaz; Lauren Clark; Carol Smith; James Vacek; John B Hiebert Journal: Am J Cardiol Date: 2022-05-27 Impact factor: 3.133
Authors: Barry A Borlaug; John Blair; Martin W Bergmann; Heiko Bugger; Dan Burkhoff; Leonhard Bruch; David S Celermajer; Brian Claggett; John G F Cleland; Donald E Cutlip; Ira Dauber; Jean-Christophe Eicher; Qi Gao; Thomas M Gorter; Finn Gustafsson; Chris Hayward; Jan van der Heyden; Gerd Hasenfuß; Scott L Hummel; David M Kaye; Jan Komtebedde; Joseph M Massaro; Jeremy A Mazurek; Scott McKenzie; Shamir R Mehta; Mark C Petrie; Marco C Post; Ajith Nair; Andreas Rieth; Frank E Silvestry; Scott D Solomon; Jean-Noël Trochu; Dirk J Van Veldhuisen; Ralf Westenfeld; Martin B Leon; Sanjiv J Shah Journal: Circulation Date: 2022-03-31 Impact factor: 39.918
Authors: Matthew Nayor; Nicholas E Houstis; Mayooran Namasivayam; Jennifer Rouvina; Charles Hardin; Ravi V Shah; Jennifer E Ho; Rajeev Malhotra; Gregory D Lewis Journal: JACC Heart Fail Date: 2020-06-10 Impact factor: 12.035
Authors: David M Kaye; Mark C Petrie; Scott McKenzie; Gerd Hasenfuβ; Filip Malek; Martijn Post; Robert N Doughty; Jean-Noël Trochu; Finn Gustafsson; Irene Lang; Adam Kolodziej; Ralf Westenfeld; Martin Penicka; Mark Rosenberg; Jörg Hausleiter; Philip Raake; Guillaume Jondeau; Martin W Bergmann; Tim Spelman; Huseyin Aytug; Piotr Ponikowski; Chris Hayward Journal: ESC Heart Fail Date: 2018-10-11
Authors: Alisa J Stephens-Shields; John T Farrar; Susan S Ellenberg; Thomas W Storer; Thomas M Gill; Shehzad Basaria; Marco Pahor; Jane A Cauley; Kristine E Ensrud; Peter Preston; David Cella; Peter J Snyder; Shalender Bhasin Journal: J Am Geriatr Soc Date: 2020-11-18 Impact factor: 5.562